您的位置: 首页 > 农业专利 > 详情页

PREDICTION OF RESPONSE TO A HER INHIBITOR
专利权人:
F. HOFFMANN-LA ROCHE AG;GENENTECH, INC
发明人:
LUKAS C. AMLER,MERRILL BIRKNER,CHIN-YU LIN,JOACHIM MOECKS,ANDREAS STRAUSS
申请号:
BRPI0808418
公开号:
BRPI0808418A2
申请日:
2008.02.29
申请国别(地区):
BR
年份:
2014
代理人:
摘要:
The present application describes the use of low HER3 as a selection criterion for treating patients with a HER inhibitor, such as pertuzumab. It also describes the use of high HER2:HER3 ratio as a selection criterion for treating cancer patients, such as ovarian cancer patients, with a HER inhibitor, such as pertuzumab. In addition, the application describes the use of high HER3 as a selection criterion for treating cancer patients with a chemotherapeutic agent, for instance gemcitabine.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充